Where Chinese Investors Meet Global Investment

中國投資者探索環球投資新聞及機遇

Medic Vision’s iQMR™ System to Allow 40% MRI Scan-Time Reduction in More Than 350 Medical Centers in China, Under a Multi-Million Dollar Agreement

Medic Vision’s iQMR™ System to Allow 40% MRI Scan-Time Reduction in More Than 350 Medical Centers in China, Under a Multi-Million Dollar Agreement

Medic Vision Imaging Solutions, the leading innovator of vendor-independent solutions for CT and MRI scanners, today announced that it has signed a multi-million dollar partnership agreement with KAME, an affiliate of Beijing Century Galaxy...

Read more
Avapritinib receives Phase III clinical trial approval for GIST in China

Avapritinib receives Phase III clinical trial approval for GIST in China

CStone Pharmaceuticals (“CStone”) today announced that the National Medical Products Administration (NMPA) recently approved a Phase III clinical trial in China for its partnered drug candidate avapritinib as a third-line treatment...

Read more
Suzhou’s CStone Pharma Schedules $304 Million Hong Kong IPO for Next Week

Suzhou’s CStone Pharma Schedules $304 Million Hong Kong IPO for Next Week

CStone Pharma, a Suzhou oncology company, plans to raise $304 million in its Hong Kong IPO at a valuation of $1.5 billion. Even though CStone is just two and one-half years-old, it has 14 oncology programs underway, including nine in clinical or...

Read more
Chemspace and LabNetwork collaborate to extend access to chemical databases

Chemspace and LabNetwork collaborate to extend access to chemical databases

Chemspace and LabNetwork, a WuXi AppTec company, both online marketplaces for chemical compounds used in drug discovery, today announced they have entered into a collaboration agreement. Under the agreement, LabNetwork’s products will be...

Read more
Burning Rock announces the completion of the Series C financing of RMB 850 million and strives to build an international leading tumor precision medicine brand

Burning Rock announces the completion of the Series C financing of RMB 850 million and strives to build an international leading tumor precision medicine brand

On February 14, 2019, Burning Rock held the signing ceremony and announced the closing of the Series C financing totaling RMB 850 million. The financing was led by GIC, followed by LYFE Capital, CMB International Capital, Lilly Asia Ventures...

Read more
Bioheng Closes $15 Million Funding from Decheng Capital for CAR-T Products

Bioheng Closes $15 Million Funding from Decheng Capital for CAR-T Products

Nanjing Bioheng Biotech completed a $15 million Series A financing, with all of the funds invested by Decheng Capital. Bioheng, which focuses on cell therapy products, is developing a universal CAR-T product that it expects will lower the cost of...

Read more
Allcure Kangtai Selects Mevion Compact Proton Therapy System to Equip Hospital in Southwest China

Allcure Kangtai Selects Mevion Compact Proton Therapy System to Equip Hospital in Southwest China

Mevion Medical Systems announced today it has signed a contract with Allcure Kangtai Proton Technology Co., Ltd. in China for the purchase of a MEVION S250i Proton Therapy System® with HYPERSCAN® Pencil Beam Scanning technology in late December...

Read more
Choom Enters into LOI with Cannabis Retail Store Applicant

Choom Enters into LOI with Cannabis Retail Store Applicant

Choom™ (CSE: CHOO; OTCQB: CHOOF) is pleased to announce that it has entered into a letter of intent agreement (“LOI”) with one of the 25 Cannabis Retail lottery winners to open a location in Ontario. Choom, an emerging adult use...

Read more
Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing

Ascletis and 3-V Biosciences Announce NASH Strategic License and Series E Financing

Ascletis Pharma Inc. (Ascletis, 1672.HK) and 3-V Biosciences, Inc. (3-V Biosciences) jointly announce today that Ascletis, through its subsidiary, and 3-V Biosciences have entered into an exclusive license agreement for 3-V Biosciences’...

Read more
Johnson & Johnson to buy surgical robotics firm Auris for $3.4 billion

Johnson & Johnson to buy surgical robotics firm Auris for $3.4 billion

Johnson & Johnson <JNJ.N> said on Wednesday it would buy Auris Health Inc for $3.4 billion (2.6 billion pounds) in cash, gaining access to the privately held company’s surgical robotic scope used in respiratory procedures and the...

Read more
Three Cannabis Stocks that Could Benefit from S. 420 in Congress

Three Cannabis Stocks that Could Benefit from S. 420 in Congress

The cannabis story is quickly gaining monumental support. All as Congressional support for cannabis legalization grows. Just last week, Democratic Sen. Ron Wyden (OR) introduced S. 420, which seeks to legalize and regulate cannabis on a federal...

Read more
China Cuts Value Added Tax on Rare Disease Drugs to 3%

China Cuts Value Added Tax on Rare Disease Drugs to 3%

China will reduce the Value Added Tax on 21 rare disease treatments to 3%, starting March 1. The State Council ordered the cuts on Monday, and said it was also directing drug regulators to speed the approval process for cancer drugs and foreign...

Read more
Do NOT follow this link or you will be banned from the site!